While true, I'm looking at the fact they failed once.
The first failure would be understandable as a late breaker. Having the same docs, with the same drug, fail again though? I'd wager that they have enough late breakers that they wouldn't be particularly enthused and would have given billing to something else.
And that isn't even going into the whole discussion on the fact that the readout should in theory be good, based on Cardiolink.
News 
Market Data 
Discover 
